BNAC at ACTRIMS Forum 2025
BNAC demonstrated a strong presence at the 2025 ACTRIMS Forum. The team shared innovative work spanning a wide range of MS research including neuroimaging phenotyping, lymphatic system dysfunction, proteomics, and connectome vulnerability. A platform presentation about the team's landmark secondary analysis of ORATORIO trial showed how artificial intelligence and advanced post-processing techniques were used to detect cortical lesions.
UB studies on MS patients reveal how paramagnetic rim lesions evolve, what they mean for disease progression
New multiple sclerosis study results revealed
Researchers from the University at Buffalo revealed their findings on Wednesday morning from a study focusing on people living with multiple sclerosis both here in Buffalo and in Boston, Massachusetts.
UB researchers report findings from first studies of patients with rare severe MS
A UB research program that is investigating what causes some people with multiple sclerosis to experience severe and aggressive disease is beginning to shed light on how their disease differs from those with mild to moderate MS.
Severe MS: UB Researchers Report Findings on Patients With Rare Form of Disease
Initial findings from UB’s Comprehensive Assessment of Severely Affected MS (CASA-MS), reveal that some of the so-called “gold standards” of MS monitoring are inadequate for patients with severe disease and that novel methods of assessing these people can be more effective
Advisory Council Spotlight: Mitch Sturgeon
Explore an insightful conversation with BNAC Advisory Council member Mitch Sturgeon as he opens up about his personal journey living with Multiple Sclerosis (MS), and why he felt inspired to join the BNAC Advisory Council.
Researcher Spotlight: Alexander Bartnik, Ph.D.
A recent graduate of the University at Buffalo’s Neuroscience program, Alexander Bartnik, PhD. is a member of BNAC’s leadership team, serving as IT Unit Director in addition to his involvement in BNAC’s Neuroinformatics Development Lab and Core Lab. His expertise lie in neuroinformatics and the development of novel tools to facilitate the translation of neuroimaging research into clinical practice.
Artificial Intelligence: Moving With the Speed of Light Into Medical Research and Practice
What is the role of AI in multiple sclerosis (MS) management? Is this technology poised to replace the jobs of neurologists and neuroradiologists?
A BNAC research team receives $1.77 million NIH grant to study oxygen metabolism in multiple sclerosis.
A team led by a BNAC faculty member, Junghun Cho, Assistant Professor in Biomedical Engineering and Neurology, has been awarded a five-year, $1.77 million Research Project Grant (R01) from the National Institutes of Health.
UB awarded $1.77 million grant to create toolset for oxygen metabolism mapping
The new technology could expand access to medical imaging; improve treatment for multiple sclerosis, Alzheimer's disease, and other neurological disorders.
Meet BNAC's newest faculty member - Niels Bergsland, PhD
Niels Bergsland is an Assistant Professor of Neurology at the State University of New York at Buffalo and serves as the Integration Director in BNAC and is part of BNAC’s leadership team.
PRLs are a Marker of a More Aggressive Ongoing Disease Course and may be a Valuable Use in Clinical Trials
A recent study conducted by a BNAC research team led by Jack Reeves, a Ph.D. candidate, showed that an imaging marker called “paramagnetic rim lesions” predicts greater multiple sclerosis (MS) related disability progression and clinical relapse frequency over 10 years.
Assessing Disability in MS Patients with the SNRS and CombiWISE Tools
Listen as Dr. Dejan Jakimovski joins the ReachMD radio program discussing his latest study and findings regarding severely affected people with multiple sclerosis.
BNAC's Commitment to Information Security: Our ISO 27k Certification
At the Buffalo Neuroimaging Analysis Center (BNAC), we take the security and privacy of data very seriously. We are proud to hold the ISO 27001 certification, a testament to our unwavering commitment to the highest standards of information security and data protection. This prestigious certification is complemented by our ISO 9001:2015 certification, which covers our overall quality system, showcasing our comprehensive approach to excellence in all operational facets.
BNAC in the Spotlight at ECTRIMS 2023
The Buffalo Neuroimaging Analysis Center (BNAC) enjoyed the spotlight at the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2023 where its researchers were recognized for an unprecedented array of publications that are shaping the field of neuroimaging in multiple sclerosis (pwMS) and related disorders.
Advancements and Challenges in Multiple Sclerosis: A Comprehensive Review in Lancet
Recent advancements in multiple sclerosis (MS) research, including improved diagnostic criteria and novel MRI techniques, have been highlighted in a new Lancet paper by researchers from the Buffalo Neuroimaging Analysis Center (BNAC) and the Jacobs MS Center for Treatment and Research.
BNAC Celebrates New Headquarters at Grand Opening
On October 5th Buffalo Neuroimaging Analysis Center celebrated the opening of its new headquarters located at the University at Buffalo's Downtown Gateway Building.
Possibilities of Measuring Cognitive Progression Independent of Relapses in MS: Tom Fuchs, MD, PhD
At MSMilan 2023, the joint ECTRIMS-ACTRIMS meeting, held October 11-13, in Milan, Italy, Tom Fuchs, MD, PhD, presented in a scientific session on the effects of MS on cognition, including cognitive progression independent of relapse activity.
Grand Opening of BNACs New Offices
Buffalo Neuroimaging Analysis Center presents the Grand Opening of our New Offices on October 5th, 2023.
MRI Scanner Launches New Biomedical Imaging Era at UB
The massive 5.5-ton Philips MR 7700 that was installed in June in the Center for Biomedical Imaging (CBI) in UB’s Clinical and Translational Research Center (CTRC) is now operational.
